Pre-clinical characterization of GMP grade CCL21-gene modified dendritic cells for application in a phase I trial in Non-Small Cell Lung Cancer.

Autor: Baratelli, Felicita1 fbaratelli@mednet.ucla.edu, Takedatsu, Hiroko1 htakedatsu@mednet.ucla.edu, Hazra, Saswati1 shazra@mednet.ucla.edu, Peebles, Katherine1 katherine.peebles@gmail.com, Jie Luo1 jluo@mednet.ucla.edu, Kurimoto, Pam S.1 pkurimoto@mednet.ucla.edu, Gang Zeng2 gzeng@mednet.ucla.edu, Batra, Raj K.1,3 rbatra@ucla.edu, Sharma, Sherven1,3 ssharma@mednet.ucla.edu, Dubinett, Steven M.1,3,4 sdubinett@mednet.ucla.edu, Lee, Jay M.1,5 jaymoonlee@mednet.ucla.edu
Zdroj: Journal of Translational Medicine. 2008, Vol. 6, Special section p1-17. 17p. 3 Charts, 6 Graphs.
Databáze: Academic Search Ultimate